ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Association of Serum Homocysteine with Cardiovascular and All-Cause Mortality in Adults with Diabetes: A Prospective Cohort Study

Lu, Jingtong; Chen, Kegong; Chen, Wei; Liu, Chang; Jiang, XingPei; Ma, Zili; Li, Dong; Shen, Yanjiao*; Tian, Hai*安徽医科大学; 哈尔滨医科大学; 四川大学; 1
Oxidative Medicine and Cellular Longevity2022-10-11DOI: 10.1155/2022/2156483
6被引8阅读
引用收藏
分享

摘要

Background. Homocysteine (Hcy) was implicated in oxidative stress and diabetes biologically. However, the clinical evidence on the link between Hcy level and diabetes is limited and controversial. This study is aimed at investigating the association of serum Hcy with all-cause and cardiovascular mortality in diabetic patients. Methods. Serum Hcy was measured among 2,286 adults with type 2 diabetes in NHANES 1999-2006. Cox proportional hazard regression was used to estimate hazard ratios (HR) and 95% CIs for the association of Hcy with all-cause and cause-specific mortality. Results. Over a median follow-up of 11.0 (interquartile range, 8.9-13.4) years, 952 of the 2286 patients with diabetes died, covering 269 (28.3%) cardiovascular deaths and 144 (15.2%) cancer deaths. Restricted cubic spline showed the linear relationship between Hcy and all-cause mortality risk. After multivariate adjustment, higher serum Hcy levels were independently associated with increased risk of all-cause and cardiovascular mortality. Compared with participants in the bottom tertile of Hcy, the multivariate-adjusted HRs and 95% CI for participants in the top quartile were 2.33 (1.64-3.30) for all-cause mortality (ptrend < 0.001), 2.24 (1.22-4.10) for CVD mortality (ptrend=0.017), and 2.05 (0.90-4.69) for cancer mortality (ptrend=0.096). The association with total mortality was especially stronger among patients with albuminuria. Serum Hcy significantly improved reclassification for 10-year mortality in diabetic patients (net reclassification index=0.253 and integrated discrimination improvement=0.011). Conclusions. Serum Hcy was associated with risks of all-cause and cardiovascular mortality in diabetic adults. Our results suggested that Hcy was a promising biomarker in risk stratification among diabetic patients.

学科与关键词

关键词
B-VITAMINSDISEASERISKIMPACT
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Oxidative Medicine and Cellular Longevity
发表日期
2022-10-11
卷期
第 2022 卷
页码
2156483
DOI
10.1155/2022/2156483
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81770347, 81401203]; Funding for the Reserve Leader of Heilongjiang Provincial Leading Talent Echelon; Key Laboratory of Education Ministry for Myocardial Ischemia Open Research Foundation [KF201919]

作者

  • L

    Lu, Jingtong (第一作者)

    2 · harbin med univ

  • C

    Chen, Kegong

    1 · anhui med univ

查看全部 9 位作者收起作者
  • C

    Chen, Wei

    2 · harbin med univ

  • L

    Liu, Chang

    2 · harbin med univ

  • J

    Jiang, XingPei

    2 · harbin med univ

  • M

    Ma, Zili

    2 · harbin med univ

  • L

    Li, Dong

    2 · harbin med univ

  • S

    Shen, Yanjiao (通讯)

    sichuan univ

  • T

    Tian, Hai (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417